BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7737184)

  • 1. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
    Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
    Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
    Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
    Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor.
    Tartare S; Mothe I; Kowalski-Chauvel A; Breittmayer JP; Ballotti R; Van Obberghen E
    J Biol Chem; 1994 Apr; 269(15):11449-55. PubMed ID: 8157675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system.
    Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E
    Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
    Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
    Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of insulin and insulin-like growth factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, phosphatidylinositol-3-kinase, and deoxyribonucleic acid synthesis.
    Chakravorty A; Joslyn MI; Davis JS
    Endocrinology; 1993 Sep; 133(3):1331-40. PubMed ID: 8396016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificities of the insulin and insulin-like growth factor 1 receptor tyrosine kinase catalytic domains.
    Xu B; Bird VG; Miller WT
    J Biol Chem; 1995 Dec; 270(50):29825-30. PubMed ID: 8530377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma.
    Kellerer M; von Eye Corleta H; Mühlhöfer A; Capp E; Mosthaf L; Bock S; Petrides PE; Häring HU
    Int J Cancer; 1995 Sep; 62(5):501-7. PubMed ID: 7665217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dimerization on signal transduction and biological function of oncogenic Ros, insulin, and insulin-like growth factor I receptors.
    Chan JL; Lai M; Wang LH
    J Biol Chem; 1997 Jan; 272(1):146-53. PubMed ID: 8995240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I receptor activated by a transmembrane mutation.
    Takahashi K; Yonezawa K; Nishimoto I
    J Biol Chem; 1995 Aug; 270(32):19041-5. PubMed ID: 7642566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
    Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
    Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors.
    Frattali AL; Pessin JE
    J Biol Chem; 1993 Apr; 268(10):7393-400. PubMed ID: 8463272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramolecular subunit interactions between insulin and insulin-like growth factor 1 alpha beta half-receptors induced by ligand and Mn/MgATP binding.
    Treadway JL; Frattali AL; Pessin JE
    Biochemistry; 1992 Dec; 31(47):11801-5. PubMed ID: 1445913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H; Yan GC; Gishizky ML
    Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase.
    Grønborg M; Wulff BS; Rasmussen JS; Kjeldsen T; Gammeltoft S
    J Biol Chem; 1993 Nov; 268(31):23435-40. PubMed ID: 7693688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-1-mediated association of p85 phosphatidylinositol 3-kinase with pp 185: requirement of SH2 domains for in vivo interaction.
    Altschuler D; Yamamoto K; Lapetina EG
    Mol Endocrinol; 1994 Sep; 8(9):1139-46. PubMed ID: 7838146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor.
    Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E
    Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
    Valverde AM; Teruel T; Lorenzo M; Benito M
    Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.